3
Announcements
Trials
Browse
Landscape
Status
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
3
Observational
1
Expanded_access
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Lymphoma
1
Leukemia
1
Interventions
balstilimab
2
zipalertinib
1
tisagenlecleucel
1
telisotuzumab vedotin
1
ribociclib
1
nirogacestat
1
mirdametinib
1
mifamurtide
1
lifileucel
1
leronlimab
1
gallium maltolate
1
futibatinib
1
fluorodopa F 18
1
dodecyl maltoside
1
ceritinib
1
carbon-11 methionine
1
capmatinib
1
brexucabtagene autoleucel
1
Sunitinib
1
Methionine
1
Alpelisib
1
3-Iodobenzylguanidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
tisagenlecleucel
×
90 days
×
Clear all
NCT03601442
2026-04-23
Managed Access Programs for CTL019, Tisagenlecleucel
Novartis
Available